Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Zinc sulphate solution was not effective in reducing the number, duration, or severity of recurrent herpes simplex infections.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Early diagnosis and treatment of Hidradenitis Suppurativa are important to prevent serious physical and mental effects.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.